Clinical trial
A Study Of Different Doses Of TBC3711 In Patients With Uncontrolled High Blood…
NCT00272961 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00272961 |
|---|---|
| Title | A Study Of Different Doses Of TBC3711 In Patients With Uncontrolled High Blood Pressure Already Taking Medications For High Blood Pressure. |
| Official title | A Phase 2 Multi-Centre, Randomised, Double-Blind, Placebo Controlled, Dose Ranging Study Of TBC3711 In Subjects With Resistant Hypertension |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Resistant Hypertension |
| Intervention type | Drug |
| Interventions | Placebo, TBC3711 |
| Enrollment | 60 |
| Start date | Jan 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Jan 9, 2006 |
| Last update posted | Mar 5, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: